Build status - In Progress

Instylla HES Hypervascular Tumor Pivotal Study

Recruiting
22 years - 99 years
All
10 participants needed
1 Location

Brief description of study

This research study is being conducted to determine if a new investigational device (Instylla Hydrogel Embolic system) can be used to treat tumors which have an extensive blood supply. This means that the tumors have many blood vessels feeding them. This product will be used to close blood vessels supplying the tumor with blood to try and shrink it (embolization). Men or women for whom vascular embolization is clinically indicated and who appear to meet eligibility criteria will be consented for the study. Participants will be in this study for approximately 7 months including the 6 months following the embolization procedure. Study will involve 5 visits to Hospital of University of Pennsylvania, which includes a screening visit.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: Medical Research, Hypervascular Tumors
  • Age: 22 years - 99 years
  • Gender: All

Men or women for whom vascular embolization is clinically indicated and who appear to meet eligibility criteria will be consented for the study.

Updated on 04 Aug 2024. Study ID: 849039

Find a site

We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

First name*
Last name*
Email*
Phone number*
Preferred way of contact
Race
Ethnicity
Other language

Interested in the study

Select a study center that’s convenient for you, and get in touch with the study team.

Contact a study center